Jan 17, 2020 - Lilly (LLY) offers to buy Dermira for $1.1 billion. AstraZeneca (AZN) and AbbVie (ABBV) provide pipeline updates.
Jan 17, 2020 - J&J's (JNJ) cancer drugs are expected to have contributed significantly to fourth-quarter 2019 earnings. Generic/biosimilar headwinds are expected to have hurt Pharma unit's sales.
Jan 17, 2020 - SLB earnings call for the period ending December 31, 2019.
Jan 21, 2020 - Berkshire Hathaway Energy's (BRK.A, BRK.B) NV Energy says it is calling for proposals to add renewable energy projects that are compliant with Nevada's renewable portfolio standards.The company says i
Jan 22, 2020 - ASML earnings call for the period ending December 31, 2019.
Jan 23, 2020 - Jazz (JAZZ) files regulatory application seeking approval for JZP-258, a low sodium formulation of Xyrem, in the United States.
Jan 28, 2020 - Jazz (JAZZ) files regulatory application seeking approval for JZP-258, a low sodium formulation of Xyrem, in the United States.
Jan 28, 2020 - Novartis (NVS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Jan 28, 2020 - The number of gene therapy candidates is expected to skyrocket in the near future.
Jan 28, 2020 - PHG earnings call for the period ending December 31, 2019.